Exact Sciences may have had disappointing Q3 earnings, but its liquidity cushions and new product approval indicate strong ...
The revised price target reflects the firm's recalibrated expectations in light of the recent financial updates provided by Exact Sciences. In other recent news, Exact Sciences has experienced a ...
Intends to lay off roughly 180 employees, amounting to 17% of its workforce, according to an SEC filing that amounts to its second recent round of layoffs ... though the exact number of employees ...
The biomedical giant best known for its Cologuard at-home colon cancer screening test reported a loss of $38.2 million, or $0.21 per share, on revenue of $708.7 million.
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called ...
Exact Sciences Corp ( (EXAS) ) has released its Q3 earnings. Here is a breakdown of the information Exact Sciences Corp presented to its ...
November 05, 2024--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq ... Core revenue is calculated to adjust for recent acquisitions and divestitures, COVID-19 testing revenue and foreign currency ...
In the latest quarter, 7 analysts provided ratings for Exact Sciences (NASDAQ:EXAS), showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
In recent weeks, tech companies have seen significant layoffs. Amazon recently laid off 18,000 employees, while Facebook and Instagram owner Meta cut 11,000 jobs. These layoffs come after all ...
The CAHSS administrative roles are being “reconstructed” into a “College-wide Support Services Team comprised of three ...
Baird analyst noted that while the recent earnings report could negatively affect investor sentiment in the short term and raise concerns about the medium-term growth prospects for Screening, the firm ...